Compare Amgen, Inc. (AMGN) vs Warner Music Group Corp (WMG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amgen, Inc. vs Warner Music Group Corp — how do they compare? Amgen, Inc. trades at $363.66 (market cap $196.12B), while Warner Music Group Corp trades at $28.82 (market cap $15.12B). The key difference: Amgen, Inc. is far larger — about 13× Warner Music Group Corp's market cap, and Amgen, Inc. pays the higher dividend (2.77%). Which is the better fit depends on your goals.
| AMGN | WMG | |
|---|---|---|
Market Cap | $196.12B | $15.12B |
Sector | Health | Media |
52-Week High | $388.16 | $34.72 |
52-Week Low | $271.18 | $23.65 |
Enterprise Value | $241.41B | $19.32B |
Dividend Yield | 2.77% | 2.62% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.
The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.
Warner Music Group (WMG) trades at $28.99, down 0.51% on the day, with a bullish technical signal driven by moving averages but mixed oscillators. The company reported revenue growth to $6.71B in 2025, though net income margin declined to 5.44%. Recent acquisitions like Sureel AI highlight strategic moves in AI-driven music attribution. Analyst consensus is strongly bullish with a $40.40 price target, implying significant upside from current levels.
WMG presents a compelling growth story with solid revenue expansion and strategic AI investments, but faces risks from margin compression and competitive pressures. The stock's high P/E of 34.51 suggests premium valuation, yet strong analyst buy ratings and institutional interest support further upside potential if execution on catalog monetization and streaming growth continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About Warner Music Group Corp
Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →
